The Multiple Myeloma market was valued at USD 28.42 Billion in 2024 and is expected to reach USD 47.04 Billion by 2032, growing at a CAGR of 6.5% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.